Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

techcrunch.com2 min read

AI drug-discovery platform Isomorphic Labs has raised $5 billion in a Series C funding round co-led by Greenoaks and Sequoia Capital. The company plans to use the capital to further develop its AI drug-design engine and advance its drug candidates into clinical trials. Isomorphic Labs was spun out of Google’s DeepMind in 2021 and builds on its breakthrough AlphaFold protein-folding technology. Open article →

More on this topic